左心室缩症的严重程度与患有缩性心肌病的患者的预后之间的关系
P M Elliott1, J R Gimeno Blanes, N G Mahon
1Department of Cardiological Sciences, St George's Hospital Medical School, London, UK. pelliott@sghms.ac.uk
Lancet (London, England)
|March 29, 2001
概括
超性心肌病患者的严重左心室缩不仅预测心脏突然死亡. 额外的风险因素是比单独的墙壁厚度更重要的预测因素.
科学领域:
- 心脏病学 心脏病学
- 临床电生理学 临床电生理学
背景情况:
- 以前的研究将严重的左心室缩 (LVH) 与高缩性心肌病 (HCM) 中的突然心脏死亡 (SCD) 风险联系起来.
- 与其他临床风险因素相比,LVH的预后值需要进一步描述.
研究的目的:
- 为了研究左心室缩的预后意义,在患有缩性心肌病的患者.
- 为了将LVH的预测值与其他突发心脏死亡临床风险因素进行比较.
主要方法:
- 研究了一组630名患有HCM的患者.
- 诊断工具包括心声回声,运动测试和霍尔特监测.
- 随访时间平均为59个月.
主要成果:
- 一个趋势显示,随着墙壁厚度的增加,SCD或ICD泄漏风险增加 (p=0.029).
- 墙壁厚度≥30毫米的患者患SCD或ICD泄漏的可能性更高 (p=0.049).
- 然而,额外的危险因素的数量是SCD或ICD排放的更强的预测因素,而不是墙壁厚度 (p=0.0001).
结论:
- 没有其他风险因素的30毫米或更多的壁厚不足以保证积极的预防性治疗.
- 轻度缩 (墙壁厚度<30毫米) 不表明突然死亡风险低,因为大多数事件发生在这个群体中.
相关概念视频
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


